Performance management of Clostridium difficile infection in hospitals - The carrot or stick approach?

Anaerobe

Volumn 37, Issue , 2016, Pages 8-12

  Fitzpatrick, Fidelma ^a,b   Riordan, Mary O ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

Author keywords

Clostridium difficile infection; Healthcare policy; Performance management; Positive deviance; Public reporting; Targets

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CLOSTRIDIUM DIFFICILE INFECTION; CULTURAL FACTOR; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL CARE; HUMAN; INFECTION CONTROL; INFLUENZA VACCINATION; MANAGED CARE; PRIORITY JOURNAL; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; EPIDEMIOLOGICAL MONITORING; HOSPITAL; ORGANIZATION AND MANAGEMENT; PEPTOCLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; EPIDEMIOLOGICAL MONITORING; HEALTH POLICY; HOSPITALS; HUMANS; INFECTION CONTROL; QUALITY INDICATORS, HEALTH CARE;

EID: 84956934695     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.10.001     Document Type: Article

References (39)

1. Institute of Medicine (IOM) Crossing the Quality Chasm: A New Health System for the 21st Century 2001, National Academy Press, Washington D.C.
2. Information Health, Authority Quality Health Information and Quality Authority Guidance on Developing Key Performance Indicators and Minimum Data Sets to Monitor Healthcare Quality 2-2-2013.
3. Longtin Y., Trottier S., Brochu G., Paquet-Bolduc B., Garenc C., Longtin J., et al. Impact of the type of diagnostic assay on clostridium difficile infection and complication rates in a mandatory reporting program. Clin. Infect. Dis. 2013, 56(1):67-73.
4. Kuijper E.J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 2006, 12(Suppl. 6):2-18.
5. The practice of management 1954, Harper and Row, New York.
6. Pearson A., Chronias A., Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J. Antimicrob. Chemother. 2009, 64(Suppl. 1):i11-i17.
7. Roede B., Monen J., van de Sande-Bruinsma N., de Kraker M., Grundsmann H. Decreasing Trends in MRSA in Europe. 19th European Congress of Clinical Microbiology and Infectious Diseases; Helsinki, Finland; May 16-19, 2009 2009, Blackwell Publishing, Chichester.
8. Duerden B.I. Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 2011, 17(4):175-179.
9. Kiernan M. Public reporting of healthcare-associated infection: professional reticence versus public interest. J. Hosp. Infect. 2013, 83(2):92-93.
10. Duerden B.I. Responsibility for managing healthcare-associated infections: where does the buck stop?. J. Hosp. Infect. 2008, 73(4):414-417.
11. Millar M., Coast J., Ashcroft R. Are meticillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective?. J. Hosp. Infect. 2008, 69(1):1-5.
12. House of Commons Public Accounts Committee Reducing Healthcare Associated Infection in Hospitals in England. Fifty-second Report of Session 2008-09 2009, National Audit Office, London.
13. Morton A., Cook D., Mengersen K., Waterhouse M. Limiting risk of hospital adverse events: avoiding train wrecks is more important than counting and reporting them. J. Hosp. Infect. 2010, 76(4):283-286.
14. Sutherland K., Leatherman S. Regulation and Quality Improvement: A Review of the Evidence 2006, The Health Foundation, London.
15. Commission for Healthcare Audit and Inspection Investigation into Outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust 2006.
16. Lim Y.W., Mattke S., Damberg C., Shekelle P.G. Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann. Intern Med. 2008, 148(2):111-123.
17. Haustein T., Gastmeier P., Holmes A. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect. Dis. 2011, 11:471-481.
18. Muller M.P., Detsky A.S. Public reporting of hospital hand hygiene compliance-helpful or harmful?. JAMA 2010, 304:1116-1117.
19. Indicateur Composite des Activités de Lutte contre les Infections Nosocomiales 2014.
20. McKibben L., Fowler G., Horan T., Brennan P.J. Ensuring rational public reporting systems for health care-associated infections: systematic literature review and evaluation recommendations. Am. J. Infect. Control 2006, 34(3):142-149.
21. Daneman N., Stukel T.A., Ma X., Vermeulen M., Guttmann A. Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada. PLoS Med. 2012, 9(7).
22. Edmond M.B., Bearman G. Mandatory public reporting in the USA: an example to follow?. J. Hosp. Infect. 2007, 65(S2):182-188.
23. Fung C.H., Lim Y.W., Mattke S., et al. Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann. Intern Med. 2008, 148(2):111-123.
24. Alston W.K. Pitfalls of public reporting. Infect. Control Hosp. Epidemiol. 2010, 31(9):985-986.
25. Yuji K., Oiso G., Matsumura T., Murashiga N., Kami M. Police investigation into multidrug-resistant Acinetobacter baumannii outbreak in Japan. Clin. Infect. Dis. 2011, 52:422.
26. Biswal M., Mewara A., Appannanavar S.B., Taneja N. Mandatory public reporting of healthcare-associated infections in developed countries: how can developing countries follow?. J. Hosp. Infect. 2015, 90(1):12-14.
27. Grimshaw J., Russell I. Achieving health gain through clinical guidelines. I: developing scientifically valid guidelines. Qual. Health Care 1993, 2(4):243-248.
28. Grimshaw J., Russell I. Achieving health gain through clinical guidelines II: ensuring guidelines change medical practice. Qual. Health Care 1994, 3(1):45-52.
29. Cabana M.D., Rand C.S., Powe N.R., et al. Why Don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282(15):1458-1465.
30. Flanagan M.E., Welsh C.A., Kiess C., Hoke S., Doebbeling B.N. A national collaborative for reducing health care-associated infections: current initiatives, challenges, and opportunities. Am. J. Infect. Control 2011, 39(8):685-689. Hospital-Acquired Infections (HAI) Collaborative.
31. Zimmerman B., Reason P., Rykert L., Gitterman L. Front-line ownership: generating a cure mindset for patient safety. Healthc. Pap. 2013, 13(1):6-22.
32. Marsh D.R., Schroeder D.G., Dearden K.A., Sternin J., Sternin M. The power of positive deviance. BMJ 2004, 329:1177-1179.
33. Lawton R., Taylor N., Clay-Williams R., Braithwaite J. Positive deviance: a different approach to achieving patient safety. BMJ Qual. Saf. 2014, 23(11):880-883.
34. Preventing C. difficile in Massachusetts Hospitals with a Mixed-Methods Learning Collaborative 2012.
35. Shaw G. Reducing methicillin-resistant Staphylococcus aureus infections in hospitals by using the positive deviance approach to organizational change. Robert Wood Johnst. Found. November 2009, Available at:. http://www.rwjf.org/content/dam/farm/reports/program_results_reports/2009/rwjf48863.
36. Reason P., Rykert L., Gardem M. Using positive deviance (PD) to reduce antibiotic resistant organisms: the Canadian PD project. BMC Proc. 2011, 5(Suppl. 6). TCPP Group, O50.
37. Marra A., Guastelli L., dos Santos O., et al. Positive deviance: a new strategy for improving hand Hygiene compliance. Infect. Control Hosp. Epidemiol. 2010, 31(1):12-20.
38. Sreeramoju P. Positive Deviance in Inpatient Wards to Reduce Hospital Infections 2015.
39. Dreer M. Healthcare personnel influenza vaccination rates without a mandate. Infect. Control Hosp. Epidemiol. 2015.